Clinical Trial Update: PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 PaTcH trial of trametinib plus hydroxychloroquine in metastatic pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• MEKINIST (trametinib)
• Plaquenil (hydroxychloroquine)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED